Cargando…

Bronchodilator Responsiveness and Reported Respiratory Symptoms in an Adult Population

BACKGROUND: The relationship between patient-reported symptoms and objective measures of lung function is poorly understood. AIM: To determine the association between responsiveness to bronchodilator and respiratory symptoms in random population samples. METHODS: 4669 people aged 40 years and older...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tan, Wan C., Bourbeau, Jean, Hernandez, Paul, Chapman, Kenneth R., Cowie, Robert, FitzGerald, J. Mark, Aaron, Shawn, Marciniuk, Darcy D., Maltais, Francois, Buist, A. Sonia, O’Donnell, Denis E., Sin, Don D.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2013
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3598856/ https://www.ncbi.nlm.nih.gov/pubmed/23554960 http://dx.doi.org/10.1371/journal.pone.0058932

Ejemplares similares

Exacerbation-like respiratory symptoms in individuals without chronic obstructive pulmonary disease: results from a population-based study
por: Tan, W C, et al.
Publicado: (2014)

Findings on Thoracic Computed Tomography Scans and Respiratory Outcomes in Persons with and without Chronic Obstructive Pulmonary Disease: A Population-Based Cohort Study
por: Tan, Wan C., et al.
Publicado: (2016)

The Prevalence of Chronic Obstructive Pulmonary Disease (COPD) and the Heterogeneity of Risk Factors in the Canadian Population: Results from the Canadian Obstructive Lung Disease (COLD) Study
por: Leung, Clarus, et al.
Publicado: (2021)

Dyspnoea and symptom burden in mild–moderate COPD: the Canadian Cohort Obstructive Lung Disease Study
por: Cherian, Mathew, et al.
Publicado: (2021)

Ambient Air Pollution and Dysanapsis: Associations with Lung Function and Chronic Obstructive Pulmonary Disease in the Canadian Cohort Obstructive Lung Disease Study
por: Bourbeau, Jean, et al.
Publicado: (2022)

Dual bronchodilation with tiotropium/olodaterol further reduces activity-related breathlessness versus tiotropium alone in COPD
por: Maltais, François, et al.
Publicado: (2019)

Three-minute constant rate step test for detecting exertional dyspnea relief after bronchodilation in COPD
por: Borel, Benoit, et al.
Publicado: (2016)

Can inhaled fluticasone alone or in combination with salmeterol reduce systemic inflammation in chronic obstructive pulmonary disease? – study protocol for a randomized controlled trial [NCT00120978]
por: Sin, Don D, et al.
Publicado: (2006)

Cardiopulmonary Exercise Testing
por: Marciniuk, Darcy D., et al.
Publicado: (2013)

Uncovering the beneficial effects of inhaled bronchodilator in COPD: beyond forced spirometry
por: Neder, José Alberto, et al.
Publicado: (2019)

Pre- and post-bronchodilator lung function as predictors of mortality in the Lung Health Study
por: Mannino, David M, et al.
Publicado: (2011)

Four patients with a history of acute exacerbations of COPD: implementing the CHEST/Canadian Thoracic Society guidelines for preventing exacerbations
por: Tsiligianni, Ioanna, et al.
Publicado: (2015)

Cluster Analysis in Patients with GOLD 1 Chronic Obstructive Pulmonary Disease
por: Gagnon, Philippe, et al.
Publicado: (2015)

Global Impact of Respiratory Disease: What Can We Do, Together, to Make a Difference?
por: Levine, Stephanie M., et al.
Publicado: (2022)

The effects of long-acting bronchodilators on total mortality in patients with stable chronic obstructive pulmonary disease
por: Kliber, Agnes, et al.
Publicado: (2010)

Can spirometric norms be set using pre- or post- bronchodilator test results in older people?
por: Kato, Bernet, et al.
Publicado: (2012)

Multi-center, randomized, placebo-controlled trial of nocturnal oxygen therapy in chronic obstructive pulmonary disease: a study protocol for the INOX trial
por: Lacasse, Yves, et al.
Publicado: (2017)

The future of bronchodilation: looking for new classes of bronchodilators
por: Cazzola, Mario, et al.
Publicado: (2019)

Effects of Tiotropium/Olodaterol on Activity-Related Breathlessness, Exercise Endurance and Physical Activity in Patients with COPD: Narrative Review with Meta-/Pooled Analyses
por: Maltais, François, et al.
Publicado: (2020)

Long-acting bronchodilators improve exercise capacity in COPD patients: a systematic review and meta-analysis
por: Di Marco, Fabiano, et al.
Publicado: (2018)

Comparative measurement properties of constant work rate cycling and the endurance shuttle walking test in COPD: the TORRACTO(®) clinical trial
por: Maltais, François, et al.
Publicado: (2020)

Worldwide patterns of bronchodilator responsiveness: results from the Burden of Obstructive Lung Disease study
por: Tan, Wan C, et al.
Publicado: (2012)

Dual bronchodilation with QVA149 versus single bronchodilator therapy: the SHINE study
por: Bateman, Eric D., et al.
Publicado: (2013)

Correction to: Long-acting bronchodilators improve exercise capacity in COPD patients: a systematic review and meta-analysis
por: Di Marco, Fabiano, et al.
Publicado: (2018)

Gender modifies the effect of body mass index on lung function decline in mild-to-moderate COPD patients: a pooled analysis
por: Chen, Wenjia, et al.
Publicado: (2021)

Ectopic adiposity and cardiometabolic health in COPD
por: Coats, Valérie, et al.
Publicado: (2018)

Heterogeneity in the respiratory symptoms of patients with mild-to-moderate COPD
por: Johnson, Kate M, et al.
Publicado: (2018)

Treatment of COPD with Long-Acting Bronchodilators: Association Between Early and Longer-Term Clinically Important Improvement
por: Vogelmeier, Claus F, et al.
Publicado: (2021)

Which bronchodilator in COPD?
por: Russell, Richard, et al.
Publicado: (2007)

COPD: maximization of bronchodilation
por: Nardini, Stefano, et al.
Publicado: (2014)

Spirometry and Bronchodilator Test
por: Sim, Yun Su, et al.
Publicado: (2017)

Salbutamol use in relation to maintenance bronchodilator efficacy in COPD: a prospective subgroup analysis of the EMAX trial
por: Maltais, F., et al.
Publicado: (2020)

Determining the influence of the primary and specialist network of care on patient and system outcomes among patients with a new diagnosis of chronic obstructive pulmonary disease (COPD)
por: Tranmer, J., et al.
Publicado: (2022)

A Novel in vivo System to Test Bronchodilators
por: Addison, Kenneth J, et al.
Publicado: (2017)

Relationship between FEV(1 )change and patient-reported outcomes in randomised trials of inhaled bronchodilators for stable COPD: a systematic review
por: Westwood, Marie, et al.
Publicado: (2011)

Bronchodilator responsiveness and dysanapsis in bronchopulmonary dysplasia
por: Nelin, Leif D., et al.
Publicado: (2022)

Novel approach to continuous adventitious respiratory sound analysis for the assessment of bronchodilator response
por: Lozano-García, Manuel, et al.
Publicado: (2017)

Effect of theophylline on exercise capacity in COPD patients treated with combination long-acting bronchodilator therapy: a pilot study
por: Voduc, Nha, et al.
Publicado: (2012)

Bronchodilators use in patients with COPD
por: Dong, Yaa-Hui, et al.
Publicado: (2015)

Dual Bronchodilator Therapy as First-Line Treatment in Maintenance-Naïve Patients with Symptomatic COPD: A Pre-Specified Analysis of the EMAX Trial
por: Bjermer, Leif, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_7ibsks2s7m70o05kr9qj0em5fm